Waterloo Capital, L.P.

Position in MDGL — Madrigal Pharmaceuticals, Inc.

CIK 1730942 Austin, TX

Position in MDGL

as of Jun 30, 2026 · filed Jul 29, 2026 Compact

Position Value

$5,329,765

New position

Shares Held

9,926

first reported quarter

Ownership

0.043%

of shares outstanding

% of Portfolio

0.67%

of 13F equity value

Holder Rank

#7

of 80 holders

Holding Since

Jun 2026

1 quarter on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Waterloo Capital, L.P. holds $7,809,642 across 5 Biotechnology names. MDGL ranks #1 (68.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	MDGL	Madrigal Pharmaceuticals, Inc. This page	9,926	$5,329,765
2	VRTX	Vertex Pharmaceuticals Inc / Ma	3,651	$1,813,561
3	INCY	Incyte Corp	2,737	$310,266
4	REGN	Regeneron Pharmaceuticals, Inc.	339	$211,380
5	DRTS	Alpha Tau Medical Ltd.	11,500	$144,670

1 filing row on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$5,329,765	9,926	—	Shares	Sole	2026-07-29
No filing history on record for this holder in this stock.